Roger Schibli - Search Results

Year	Number of Results
1998	1
2002	2
2003	2
2004	1
2005	4
2006	7
2007	5
2008	10
2009	6
2010	13
2011	9
2012	18
2013	31
2014	23
2015	20
2016	17
2017	24
2018	21
2019	25
2020	29
2021	20
2022	17
2023	11
2024	7

1

Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder.

Vaccarin C, Mapanao AK, Deberle LM, Becker AE, Borgna F, Marzaro G, Schibli R, Müller C. Vaccarin C, et al. Among authors: schibli r. Cancers (Basel). 2024 Mar 23;16(7):1262. doi: 10.3390/cancers16071262. Cancers (Basel). 2024. PMID: 38610940 Free PMC article.

2

In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [¹⁷⁷Lu]Lu-PP-F11N in humans: the lumed phase 0b study.

Rottenburger C, Hentschel M, Fürstner M, McDougall L, Kottoros D, Kaul F, Mansi R, Fani M, Vija AH, Schibli R, Geistlich S, Behe M, Christ ER, Wild D. Rottenburger C, et al. Among authors: schibli r. EJNMMI Res. 2024 Apr 6;14(1):37. doi: 10.1186/s13550-024-01101-w. EJNMMI Res. 2024. PMID: 38581480 Free PMC article.

3

Liquid Chromatography ICP-MS to Assess the Stability of ¹⁷⁵Lu- and ^natGa-Based Tumor-Targeting Agents towards the Development of ¹⁷⁷Lu- and ⁶⁸Ga-Labeled Radiopharmaceuticals.

Wallimann RH, Hensinger H, Müller C, Schibli R, Kneuer R, Schindler P. Wallimann RH, et al. Among authors: schibli r. Pharmaceutics. 2024 Feb 21;16(3):299. doi: 10.3390/pharmaceutics16030299. Pharmaceutics. 2024. PMID: 38543193 Free PMC article.

4

First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([¹⁶¹Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum.

Fricke J, Westerbergh F, McDougall L, Favaretto C, Christ E, Nicolas GP, Geistlich S, Borgna F, Fani M, Bernhardt P, van der Meulen NP, Müller C, Schibli R, Wild D. Fricke J, et al. Among authors: schibli r. Eur J Nucl Med Mol Imaging. 2024 Mar 7. doi: 10.1007/s00259-024-06641-w. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 38448550 No abstract available.

5

Preclinical Evaluation of the Reversible Monoacylglycerol Lipase PET Tracer (R)-[¹¹C]YH132: Application in Drug Development and Neurodegenerative Diseases.

He Y, Delparente A, Jie CVML, Keller C, Humm R, Heer D, Collin L, Schibli R, Gobbi L, Grether U, Mu L. He Y, et al. Among authors: schibli r. Chembiochem. 2024 Apr 2;25(7):e202300819. doi: 10.1002/cbic.202300819. Epub 2024 Mar 5. Chembiochem. 2024. PMID: 38441502

6

Relaxed fibronectin: a potential novel target for imaging endometriotic lesions.

Trachsel B, Imobersteg S, Valpreda G, Singer G, Grabherr R, Ormos M, Burger IA, Kubik-Huch RA, Schibli R, Vogel V, Béhé M. Trachsel B, et al. Among authors: schibli r. EJNMMI Res. 2024 Feb 10;14(1):17. doi: 10.1186/s13550-024-01070-0. EJNMMI Res. 2024. PMID: 38340184 Free PMC article.

7

Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer's disease: A [¹⁸F]PSS232 PET/MRI study.

Wang J, He Y, Chen X, Huang L, Li J, You Z, Huang Q, Ren S, He K, Schibli R, Mu L, Guan Y, Guo Q, Zhao J, Xie F. Wang J, et al. Among authors: schibli r. Alzheimers Res Ther. 2024 Jan 12;16(1):9. doi: 10.1186/s13195-024-01385-z. Alzheimers Res Ther. 2024. PMID: 38217040 Free PMC article.

8

Detecting radio- and chemoresistant cells in 3D cancer co-cultures using chromatin biomarkers.

Pekeč T, Venkatachalapathy S, Shim AR, Paysan D, Grzmil M, Schibli R, Béhé M, Shivashankar GV. Pekeč T, et al. Among authors: schibli r. Sci Rep. 2023 Nov 24;13(1):20662. doi: 10.1038/s41598-023-47287-2. Sci Rep. 2023. PMID: 38001169 Free PMC article.

9

Proof-of-concept optimization of a copper-mediated ¹⁸F-radiosynthesis of a novel MAGL PET tracer on a high-throughput microdroplet platform and its macroscale translation.

Lu Y, He Y, Schibli R, Mu L, van Dam RM. Lu Y, et al. Among authors: schibli r. Lab Chip. 2023 Oct 24;23(21):4652-4663. doi: 10.1039/d3lc00735a. Lab Chip. 2023. PMID: 37818614

10

Investigations Using Albumin Binders to Modify the Tissue Distribution Profile of Radiopharmaceuticals Exemplified with Folate Radioconjugates.

Busslinger SD, Becker AE, Vaccarin C, Deberle LM, Renz ML, Groehn V, Schibli R, Müller C. Busslinger SD, et al. Among authors: schibli r. Cancers (Basel). 2023 Aug 25;15(17):4259. doi: 10.3390/cancers15174259. Cancers (Basel). 2023. PMID: 37686538 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

283 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

283 results

Results by year